Le Lézard
Classified in: Science and technology
Subject: CCA

Media Advisory: CAE's FY2024 third quarter financial results and conference call


MONTREAL, Feb. 8, 2024 /CNW/ - (NYSE: CAE; TSX: CAE) ? CAE will release its fiscal year 2024 third quarter results on Wednesday, February 14, 2024. A conference call will be held on the same day at 2 p.m. Eastern Time (ET) to provide analysts and institutional investors with a review of CAE's performance and outlook.

Marc Parent, CAE's President and Chief Executive Officer, Sonya Branco, CAE's Executive Vice President, Finance and Chief Financial Officer, and Andrew Arnovitz, CAE's Senior Vice President, Investor Relations and Enterprise Risk Management, will participate in this call intended for financial analysts, institutional investors and the media. Please note that the media will have the opportunity to ask questions immediately following the analysts' question period.

The meeting will be webcast live on CAE's site at www.cae.com. The webcast will be archived following the event.

Event:        CAE's FY2024 Q3 financial results and conference call

Date:        Wednesday, February 14, 2024

Time:          2:00 p.m. ET

Webcast: The conference call will be audio Webcast live for the public at https://www.gowebcasting.com/13153 and will also be archived for 90 days following the event at  www.cae.com/investors/

Phone numbers for conference call:

Country 

Phone number 

North America  

877 586 3392

Canada 

+1 416 981 9024

Australia 

1800642038

Belgium 

080077657

France 

0800919393

Germany 

08001816101

Netherlands 

08000222280

Singapore 

8001012594

United Kingdom 

08004960381

Instant replay (available three hours after the call ends for 48 hours): 1-800-558-5253 or +1-416-626-4100 - Access code: 22029075.

About CAE

At CAE, we equip people in critical roles with the expertise and solutions to create a safer world. As a technology company, we digitalize the physical world, deploying software-based simulation training and critical operations support solutions. Above all else, we empower pilots, cabin crew, airlines, defence and security forces and healthcare practitioners to perform at their best every day and when the stakes are the highest. Around the globe, we're everywhere customers need us to be with more than 13,000 employees in approximately 250 sites and training locations in over 40 countries. CAE represents more than 75 years of industry firsts?the highest-fidelity flight, mission and medical simulators and training programs powered by digital technologies. We embed sustainability in everything we do. Today and tomorrow, we'll make sure our customers are ready for the moments that matter. Read our FY23 Global Annual Activity and Sustainability Report.

Contacts:

General Media:
Samantha Golinski, Vice President, Public Affairs & Global Communications
+1-514-340-7939, ext 7939, [email protected]

Investor Relations:
Andrew Arnovitz, Senior Vice President, Investor Relations and Enterprise Risk Management, +1-514-734-5760, [email protected]

SOURCE CAE Inc.


These press releases may also interest you

at 07:10
POSaBIT Systems Corporation (the "Company" or "POSaBIT") announces today that the Company is anticipating a delay in filing its annual financial statements and accompanying management's discussion and analysis for the year ended December 31, 2023...

at 07:06
Recently, at Auto China 2024, Neusoft Corporation (Neusoft, SSE:600718) launched OneCoreGo® Global In-Vehicle Intelligent Mobility Solutions 5.0, showcasing its innovative achievements in the AI+ Automotive field. It's also one of the series of...

at 07:05
Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based on defined bacterial consortia, today announced that members of its executive team will participate at the following investor...

at 07:05
Alentis Therapeutics ("Alentis"), a clinical-stage biotechnology company developing treatments for organ fibrosis and Claudin-1 positive tumors, announced today that Dr. Alberto Toso has been appointed as Chief Scientific Officer effective...

at 07:05
Deciphera Pharmaceuticals, Inc. , a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that it has entered into a definitive merger...

at 07:05
bit.bio, the company coding human cells for novel cures, and a pioneer in the field of synthetic biology, today announces it will participate in an engaging fireside chat at SynBioBeta 2024 featuring Nobel Laureate Thomas Südhof and bit.bio founder...



News published on and distributed by: